Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model

BACKGROUND: Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated sequela of group A streptococcal (GAS) infections, with nephritogenic GAS antigens implicated in its pathogenesis. Seroepidemiological evidence also implicates GAS streptococcal inhibitor of complement (SIC) in the development of PSGN. This association is supported by elevated anti-SIC antibody responses in patients with PSGN, suggesting a possible role for these antibodies in disease pathogenesis. METHODS: To investigate whether antibodies generated against SIC are associated with renal pathology, Lewis rats were administered recombinant SIC (rSIC), its domain containing the long repeat region (LRR) and proline-rich region (PRR), or rSIC combined with inactivated whole-cell GAS (IWG) in a series of experiments. Serum antibody responses were evaluated using enzyme-linked immunosorbent assays. Renal alterations were assessed by biochemical analyses of serum and urinary albumin, creatinine, and urea; urinalysis for microhematuria and albumin-to-creatinine ratio; histopathology; and immunofluorescence analysis of immunoglobulin G (IgG) and complement C3 deposition. Systemic complement activation was evaluated by measuring serum C3a levels. RESULTS: Although robust anti-SIC antibody responses (p < 0.0001) were observed in all rats exposed to the various SIC formulations or domain, no renal functional impairment, histopathological injury, urinary abnormalities, or significant alterations in serum C3a levels were identified. In the absence of overt renal abnormalities, immunofluorescence revealed only focal low-grade glomerular IgG deposition but no detectable C3 deposition. CONCLUSIONS: In this Lewis rat model, antibodies to rSIC did not drive PSGN-like renal pathology. This suggests that SIC-specific humoral responses alone may be insufficient for disease development, potentially reflecting the multifactorial nature of PSGN pathogenesis.

Authors

Institutions

Publication Details

Journal
Animal Models and Experimental Medicine
Published
2026-11-16
DOI
https://doi.org/10.1002/ame2.70305
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model

Kadaba S. Sriprakash, Kirstan A. Vessey, David J. McMillan, Mohammad Raguib Munif et al.
Animal Models and Experimental Medicine
Renal Diseases and Glomerulopathies
article

Antibodies generated against recombinant streptococcal inhibitor of complement do not trigger detectable renal pathology in a Lewis rat model

Kadaba S. Sriprakash, Kirstan A. Vessey, David J. McMillan, Mohammad Raguib Munif, Rukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Robert A. de J. Hart
article en

Abstract

BACKGROUND: Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated sequela of group A streptococcal (GAS) infections, with nephritogenic GAS antigens implicated in its pathogenesis. Seroepidemiological evidence also implicates GAS streptococcal inhibitor of complement (SIC) in the development of PSGN. This association is supported by elevated anti-SIC antibody responses in patients with PSGN, suggesting a possible role for these antibodies in disease pathogenesis. METHODS: To investigate whether antibodies generated against SIC are associated with renal pathology, Lewis rats were administered recombinant SIC (rSIC), its domain containing the long repeat region (LRR) and proline-rich region (PRR), or rSIC combined with inactivated whole-cell GAS (IWG) in a series of experiments. Serum antibody responses were evaluated using enzyme-linked immunosorbent assays. Renal alterations were assessed by biochemical analyses of serum and urinary albumin, creatinine, and urea; urinalysis for microhematuria and albumin-to-creatinine ratio; histopathology; and immunofluorescence analysis of immunoglobulin G (IgG) and complement C3 deposition. Systemic complement activation was evaluated by measuring serum C3a levels. RESULTS: Although robust anti-SIC antibody responses (p < 0.0001) were observed in all rats exposed to the various SIC formulations or domain, no renal functional impairment, histopathological injury, urinary abnormalities, or significant alterations in serum C3a levels were identified. In the absence of overt renal abnormalities, immunofluorescence revealed only focal low-grade glomerular IgG deposition but no detectable C3 deposition. CONCLUSIONS: In this Lewis rat model, antibodies to rSIC did not drive PSGN-like renal pathology. This suggests that SIC-specific humoral responses alone may be insufficient for disease development, potentially reflecting the multifactorial nature of PSGN pathogenesis.

Animal Models and Experimental Medicine
University of the Sunshine Coast (AU), Bangladesh Agricultural University (BD), University of New England (AU)
National Health and Medical Research Council
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon